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Abstract The objective of this study was to investigate
associations between leisure-time physical activity, low
high-density lipoprotein cholesterol (HDL-C) and mortal-
ity. Self-reported leisure-time physical activity, HDL-C
concentration, and mortality were assessed in 37,059 adults
in Health Survey for England and Scottish Health Survey.
Meeting physical activity guidelines was defined as C150
min wk-1 of moderate-intensity activity, C75 min wk-1 of
vigorous-intensity activity, or equivalent combinations.
Low HDL-C was defined as\1.03 mmol L-1. Cox pro-
portional hazard models were adjusted for age, sex,
smoking, total cholesterol, systolic blood pressure, body
mass index, longstanding illness, and socioeconomic sta-
tus. There were 2250 deaths during 326,016 person-years
of follow-up. Compared with those who met physical
activity guidelines and whose HDL-C was normal (refer-
ence group), all-cause mortality risk was not elevated in
those who met physical activity guidelines and whose
HDL-C concentration was low (hazard ratio: 1.07; 95%
confidence interval: 0.75, 1.53). Compared with the refer-
ence group, all-cause mortality risk was elevated in those
who did not meet physical activity guidelines and whose
HDL-C was normal (1.37; 1.16, 1.61), and in those who did
not meet physical activity guidelines and whose HDL-C
was low (1.65; 1.37, 1.98). Cardiovascular disease mor-
tality hazard ratios were similar, although confidence
intervals were wider. There was no statistically significant
evidence of biological interaction between physical inac-
tivity and low HDL-C. This novel study supports the notion
that leisure-time physical activity be recommended in those
with low HDL-C concentration who may be resistant to the
HDL-raising effect of exercise training.
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Introduction
In the Third Report of the US National Cholesterol Edu-
cation Program Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III [ATP III]), it stated that low high-
density lipoprotein cholesterol (HDL-C) was an indepen-
dent risk factor for coronary heart disease [1]. Physical
activity and other therapeutic lifestyle changes were rec-
ommended to reduce cardiovascular disease (CVD) risk in
those with low HDL-C in ATP III and in a subsequent
report from the Coordinating Committee of the National
Cholesterol Education Program [2]. Physical inactivity is
regarded as a cause of low HDL-C levels [1] and exercise
training tends to increase HDL-C [3]. Leisure-time physi-
cal activity is associated with reduced risks of mortality
from CVD and all causes [4, 5]. Low HDL-C is associated
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with increased risks of mortality from CVD and all causes
[6, 7]; However, the relationships between physical activ-
ity, low HDL-C and mortality are unclear. The benefits of
HDL-raising drugs are ambiguous [8] and some people
may be resistant to the HDL-raising effect of exercise
[9–12]. The objective of this study was to investigate
associations between leisure-time physical activity, low
HDL-C and mortality in a pooled analysis of nine popu-
lation-based cohorts in Britain.
Methods
Participants
The Health Survey for England (HSE) and the Scottish
Health Survey (SHS) are household-based surveillance
studies that are described in detail elsewhere [13, 14]. The
present study included participants from surveys in 1995
(SHS only), 1998 (HSE and SHS), 1999 (HSE only), 2003
(HSE and SHS), 2004 (HSE only), 2006 (HSE only), and
2008 (HSE only). The same organization carried out the
surveys using consistent methods [13, 14]. The HSE and
SHS samples were selected using a multistage, stratified
probability design to be representative of the target popu-
lations of the corresponding countries. Stratification was
based on geographical areas and not on individual char-
acteristics: postcode (zip code) sectors were selected at the
first stage and household addresses selected at the second
stage. Local research ethics committees approved all
aspects of each survey and all participants gave written
informed consent.
Physical activity
Trained interviewers asked participants about physical
activity. The questionnaires used to assess physical activity
in the HSE and SHS surveys are described in detail else-
where [15]. Briefly, the interviewer used the questionnaire
to inquire about the following aspects of the respondent’s
physical activity in the four weeks before the interview:
frequency and duration of participation in domestic phys-
ical activity (light and heavy housework, gardening, and
do-it-yourself tasks); frequency, duration and pace of
walking (slow, average, brisk, or fast); and participation in
sports and exercises using a prompt card showing 10 main
groups, including cycling, swimming, running, football,
rugby, tennis, and squash. Six open entries could also be
recorded. For each sport and exercise, the respondent was
asked to specify frequency, duration, and perceived inten-
sity. The validity [16] and reliability [17] of the question-
naires have been reported. One metabolic equivalent
(MET) was considered to represent resting energy
expenditure and activities were quantified in terms of
multiples of resting energy expenditure. A compendium of
physical activities was used to assign MET values [18].
Light-intensity activities (such as ‘‘light’’ gardening activ-
ity and slow-paced walking) were assigned MET values of
1.5–2.9; moderate-intensity activities (such as brisk/fast
walking and a subset of sports and exercises) were assigned
MET values of 3.0–5.9; and, vigorous-intensity activities
(such as swimming, jogging and running) were assigned
MET values of C6.0 METs. Leisure-time activities and
domestic activities are included in prevailing physical
activity guidelines [19]; however, domestic activities were
not included in the present analysis because of the reported
lack of association between domestic activity and mortality
[20, 21]. Meeting physical activity guidelines was defined
as taking part in at least 150 min per week of moderate-
intensity leisure-time physical activity, or at least 75 min
per week of vigorous-intensity leisure-time physical
activity, or any combination of moderate- and vigorous-
intensity physical activity equivalent to at least 7.5 MET-
h wk-1 [19]. A MET-hour is computed by multiplying the
MET score of an activity by the time performed [18].
Clinical data
Trained interviewers measured height and weight and
asked about smoking habit and longstanding illness. Body
mass index (BMI) was expressed as kilograms per meter
squared. Longstanding illness was defined as any illness,
disability or infirmity that had troubled the respondent over
a period of time or was likely to affect them over a period
of time. A longstanding illness was defined as limiting if
the respondent said that it limited their activities in any
way. Trained and qualified nurses asked about the use of
CVD medication, including beta blockers, ACE inhibitors,
diuretics, calcium blockers, and lipid lowering agent. The
nurses also measured blood pressure and obtained a non-
fasting venous blood sample. Blood pressure was measured
three times after 5 min of seated rest. In this study, systolic
blood pressure was computed as the average of the second
and third readings. Blood samples were sent to the Bio-
chemistry Department at the Royal Victoria Infirmary in
Newcastle for the measurement of total cholesterol and
HDL-C (640 analyser, Olympus Corporation, Tokyo,
Japan). Detailed information on the methodology of the
blood analysis, the internal quality control, and the external
quality assessment for the laboratory have been described
elsewhere [22]. The coefficient of variation of the assays
was\4%. In keeping with previous work [7], the ATP III
sex-specific definition was used to define low HDL-C:
\1.03 mmol L-1 in men and\1.30 mmol L-1 in women
[1].
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Socioeconomic status
Socioeconomic status was assessed using the four-group
version of the Registrar General’s classification: profes-
sional and managerial occupations; skilled, non-manual
occupations; skilled manual occupations; and, routine and
manual occupations.
Mortality follow-up
Participants were flagged by the British National Health
Service Central Registry. For participants who survived,
the data were censored up to the end of 2009 (Scottish
Health Survey) or the first quarter of 2011 (Health Survey
for England). Diagnoses for the primary cause of death
were based on the International Classification of Diseases,
Ninth (ICD-9) and Tenth (ICD-10) Revisions. Codes cor-
responding to CVD mortality were 390-459 for ICD-9 and
I01-I99 for ICD-10.
Statistical analysis
The Cox proportional hazards model was used to estimate
the associations of physical activity and HDL-C on the
risks of all-cause and CVD mortality. The proportional
hazards assumption was examined by comparing the
cumulative hazard plots grouped on exposure, although no
appreciable violations were noted. For the present analyses,
calendar time (months) was the timescale. Data from 371
participants who died during the first 24 months of follow-
up were not included in the present analysis to address the
issue of reverse causation, where participants with under-
lying disease are less likely to be physically active (there
were 371 deaths from all causes, including 61 from CVD).
Analyses were adjusted for age and sex (Model 1) and
further adjusted for smoking, total cholesterol, systolic
blood pressure, body mass index, longstanding illness, and
socioeconomic status (Model 2). It has been argued that
models should include variables that are thought to be
important in the literature [23]. The literature suggests that
the variables included in Model 1 and Model 2 are
important chronic disease risk factors [1]. Three sensitivity
analyses were performed. First, low HDL-C was defined as
\1.03 mmol L-1 in both men and women [1] to investi-
gate whether the use of a single definition influenced the
associations between physical activity, HDL-C and mor-
tality. Second, the associations between physical activity,
HDL-C and mortality were investigated in the subsample
with medication data to further address the issue of reverse
causation. Third, the associations between physical activ-
ity, HDL-C and mortality were investigated in the sub-
sample aged 40 years and older because it was thought that
congenital abnormalities would be responsible for events in
young individuals and lifestyle would be responsible for
events in middle-aged and older adults [24]. Three mea-
sures of biological interaction were used to investigate
biological interaction between physical inactivity and low
HDL-C, as described by Andersson and colleagues [25]:
the relative excess risk due to interaction (RERI); the
attributable proportion due to interaction (AP); and the
synergy index (S) (RERI and AP would be equal to 0 and S
would be equal to 1 if there were no biological interaction
[25]). Population attributable risks were calculated based
on all-cause mortality. All analyses were performed using
SPSS version 22 (IBM Inc.).
Results
There were 37,059 participants included in the present
study. Some 90% of participants were white and other
broad ethnic groups included black (2.6%), Asian (6.7%),
and Chinese (1.9%). Table 1 shows participants’ charac-
teristics at baseline according to the meeting of physical
activity guidelines and HDL-C concentration. Some 30%
of participants met physical activity guidelines. In those
who met physical activity guidelines, age tended to be
lower, the proportion of men tended to be higher, the
proportion reporting longstanding illness tended to be
lower, and the proportion employed in professional occu-
pations tended to be higher. Cardiovascular disease
prevalence and CVD medication use were lower in those
who met physical activity guidelines than those who did
not. Body mass index, total cholesterol, and systolic blood
pressure tended to be lower in those who met physical
activity guidelines, but there was considerable overlap with
those who did not meet physical activity guidelines. High-
density lipoprotein cholesterol concentration was around
1.6 mmol L-1 in those with normal concentrations and
around 1.0 mmol L-1 in those with low concentrations.
Low HDL-C was identified in 15% of those who met
physical activity guidelines and 22% of those who did not.
The partial correlation adjusted for age and sex between
non-occupational physical activity (MET-h wk-1) and
HDL-C (mmol L-1) was 0.10 (p\ 0.001). Table S1 in the
Online Supplement shows participants’ age, HDL-C and
physical activity by survey and survey year.
There were 2250 deaths from all causes, including 649
from CVD, during 326,016 person years of follow-up
(mean: 8.8 years of follow-up [range: 2–15 years]). Sur-
vival curves for all-cause mortality and CVD mortality
according to exposure are shown in the Online Supplement
(Figures S1 and S2, respectively). Table 2 shows the
associations between physical activity, HDL-C and all-
cause mortality with low HDL-C defined as
\1.03 mmol L-1 in men and\1.30 mmol L-1 in women.
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Compared with those who met physical activity guidelines
and whose HDL-C concentration was normal (the reference
group), the fully-adjusted hazard ratio for all-cause mor-
tality was 1.07 and the 95% confidence interval included
zero (0.75, 1.53) in those who met physical activity
guidelines and whose HDL-C concentration was low.
Compared with the reference group, the fully-adjusted
hazard ratio for all-cause mortality was 1.37 (95% CI: 1.16,
1.61) in those who did not meet physical activity guidelines
and whose HDL-C concentration was normal, and 1.65
Table 1 Participants’ characteristics at baseline (n = 37,059)
Meeting physical activity guidelines
(n = 10,898)a
Not meeting physical activity guidelines
(n = 26,161)a
Normal HDL-Cb Low HDL-Cb Normal HDL-Cb Low HDL-Cb
Age (years) 41 ± 15 38 ± 14 50 ± 16 47 ± 16
Sex (% male) 51.9 53.8 42.2 42.5
Body mass index (kg m-2) 25.5 ± 3.9 27.8 ± 4.8 26.5 ± 4.6 28.8 ± 5.2
HDL-C (mmol L-1) 1.6 ± 0.4 1.0 ± 0.2 1.6 ± 0.4 1.0 ± 0.2
Total cholesterol (mmol L-1) 5.4 ± 1.1 5.1 ± 1.1 5.7 ± 1.1 5.5 ± 1.2
Systolic blood pressure (mm Hg) 126.2 ± 15.8 126.6 ± 15.1 131.0 ± 19.1 131.1 ± 19.1
Smoker (%) 17.6 27.0 23.5 31.9
Non-occupational activity (MET-h wk-1) 49.6 ± 46.2 49.0 ± 57.6 16.8 ± 25.3 15.0 ± 24.0
Longstanding illness (%) 30.6 35.2 44.6 49.5
Cardiovascular disease prevalence (%)c 1.1 1.5 4.1 6.7
Cardiovascular disease medication (%)d 13.0 16.6 25.2 29.6
Social occupational group (% professional) 7.7 5.8 4.4 3.3
a Here, physical activity excludes domestic activity and meeting physical activity guidelines is defined as taking part in at least 150 min per
week of moderate-intensity physical activity, or at least 75 min per week of vigorous-intensity physical activity, or any combination of moderate-
and vigorous-intensity physical activity equivalent to at least 7.5 MET-h wk-1
b Here, low HDL-C defined as\1.03 mmol L-1 in men and\1.30 mmol L-1 in women
c Cardiovascular disease prevalence includes doctor-diagnosed heart attack, stroke, or angina
d Cardiovascular disease medication includes beta blockers, ACE inhibitors, diuretics, calcium blockers, and lipid lowering agents
Data are mean ± SD unless indicated otherwise
Table 2 Cox proportional hazard ratios (HR) for associations between physical activity, high-density lipoprotein cholesterol (HDL-C) and all-
cause and cardiovascular disease mortality with low HDL-C defined differently in men and women (n = 37,059)
Meeting physical activity guidelinesa HDL-Cb Deaths/N Age- and sex-adjusted HR (95% CI) Fully-adjusted HR (95% CI)c
All-cause mortality
Yes Normal 170/9234 1.0 (Reference) 1.0 (Reference)
Yes Low 40/1664 1.13 (0.80, 1.60) 1.07 (0.75, 1.53)
No Normal 1514/20,487 1.58 (1.35, 1.86) 1.37 (1.16, 1.61)
No Low 526/5674 1.98 (1.66, 2.35) 1.65 (1.37, 1.98)
Cardiovascular disease mortality
Yes Normal 48/9234 1.0 (Reference) 1.0 (Reference)
Yes Low 7/1664 0.71 (0.32, 1.56) 0.60 (0.25, 1.40)
No Normal 418/20,487 1.36 (1.00, 1.84) 1.11 (0.82, 1.52)
No Low 176/5674 2.13 (1.54, 2.94) 1.63 (1.16, 2.27)
a Here, physical activity excludes domestic activity and meeting physical activity guidelines is defined as taking part in at least 150 min per
week of moderate-intensity physical activity, or at least 75 min per week of vigorous-intensity physical activity, or any combination of moderate-
and vigorous-intensity physical activity equivalent to at least 7.5 MET-h wk-1
b Here, low HDL-C defined as\1.03 mmol L-1 in men and\1.30 mmol L-1 in women
c Model adjusted for age, sex, smoking, total cholesterol, systolic blood pressure, body mass index, longstanding illness, and social class
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(95% CI: 1.37, 1.98) in those who did not meet physical
activity guidelines and whose HDL-C concentration was
low. The associations were similar in magnitude and
direction in the subsamples with medication data
(Table S2, Online Supplement) and aged 40 years and
older (Table S3, Online Supplement). The associations
between physical activity, HDL-C and all-cause mortality
were also similar after further adjustment for survey year
(Table S4, Online Supplement). The associations between
the covariates and mortality are shown in Table S5 in the
Online Supplement.
Table 2 also shows the associations between physical
activity, HDL-C and CVD mortality with low HDL-C
defined as\1.03 mmol L-1 in men and\1.30 mmol L-1
in women. Compared with those who met physical activity
guidelines and whose HDL-C concentration was normal
(the reference group), the fully-adjusted hazard ratio for
CVD mortality was 0.60 (95% CI: 0.25, 1.40) in those who
met physical activity guidelines and whose HDL-C con-
centration was low. Compared with the reference group,
the fully-adjusted hazard ratio for CVD mortality was 1.11
(95% CI: 0.82, 1.52) in those who did not meet physical
activity guidelines and whose HDL-C concentration was
normal, and 1.63 (95% CI: 1.16, 2.27) in those who did not
meet physical activity guidelines and whose HDL-C con-
centration was low. Table 3 shows the associations
between physical activity and mortality with low HDL-C
defined as\1.03 mmol L-1 in men and women. The use of
a single definition of low HDL-C and the resultant reallo-
cation of women had little impact on the magnitudes of the
hazard ratios or the widths of the confidence intervals.
Figure 1 shows the relative risk of all-cause mortality with
contributions from physical inactivity and low HDL-C.
There was no statistically significant evidence of biological
interaction between physical inactivity and low HDL-C.
Table S6 in the Online Supplement shows the calcula-
tion of population attributable risks based on all-cause
mortality. It was calculated that, if everybody were to
adhere to physical activity guidelines, there would be a
reduction of 4.1 new mortality cases per 100 population.
Such a reduction represents a 68.2% reduction of the
incidence in the population. It was also calculated that, if
everybody were to have normal HDL-C, there would be a
reduction of 0.4 new mortality cases per 100 population.
Such a reduction represents a 6.6% reduction of the inci-
dence in the population.
Discussion
The objective of this study was to investigate associations
between leisure-time physical activity, low HDL-C and
mortality. The main findings were that the risks of all-cause
and CVD mortality were similar in both those who met
physical activity guidelines and whose HDL-C concentra-
tion was normal and those who met physical activity
guidelines and whose HDL-C concentration was low.
There was no statistically significant evidence of biological
interaction between physical inactivity and low HDL-C;
rather, the relative risks of all-cause mortality were addi-
tive. This study supports the notion that physical activity be
recommended in those with low HDL-C.
Table 3 Cox proportional hazard ratios (HR) for associations between physical activity, high-density lipoprotein cholesterol (HDL-C) and all-
cause and cardiovascular disease mortality with low HDL-C defined similarly in men and women (n = 37,059)
Meeting physical activity guidelinesa HDL-Cb Deaths/N Age- and sex-adjusted HR (95% CI) Fully-adjusted HR (95% CI)c
All-cause mortality
Yes Normal 180/9774 1.0 (Reference) 1.0 (Reference)
Yes Low 30/1124 1.13 (0.74, 1.66) 1.05 (0.70, 1.56)
No Normal 1679/22,682 1.60 (1.37, 1.87) 1.38 (1.17, 1.61)
No Low 361/3479 1.96 (1.64, 2.35) 1.65 (1.37, 1.99)
Cardiovascular disease mortality
Yes Normal 48/9774 1.0 (Reference) 1.0 (Reference)
Yes Low 7/1124 0.96 (0.44, 2.13) 0.79 (0.34, 1.86)
No Normal 472/22,682 1.49 (1.10, 2.01) 1.19 (0.88, 1.63)
No Low 122/3479 2.20 (1.57, 3.08) 1.72 (1.20, 2.43)
a Here, physical activity excludes domestic activity and meeting physical activity guidelines is defined as taking part in at least 150 min per
week of moderate-intensity physical activity, or at least 75 min per week of vigorous-intensity physical activity, or any combination of moderate-
and vigorous-intensity physical activity equivalent to at least 7.5 MET-h wk-1
b Here, low HDL-C defined as\1.03 mmol L-1 in men and women
c Model adjusted for age, sex, smoking, total cholesterol, systolic blood pressure, body mass index, longstanding illness, and social class
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According to ATP III, therapeutic lifestyle changes
include: reduced intake of saturated fats and cholesterol;
therapeutic dietary options to enhance low-density
lipoprotein cholesterol lowering (plant stanols/sterols and
increased viscous fibre); weight control, and increased
physical activity [1]. Therapeutic lifestyle changes and
drugs are explicitly recommended in those with high low-
density lipoprotein cholesterol concentrations according to
CVD risk [1, 2]. The roles of therapeutic lifestyle changes
and drugs are ambiguous in those with low HDL-C con-
centrations [1, 2]. Around 20% of adults in the present
study had low HDL-C and 37% of 15,252 white men and
women in four American studies had low HDL-C [26].
Data from the four American studies suggest that coronary
heart disease incidence and all-cause mortality rates are
higher in adults with low HDL-C than high HDL-C (\1.04
and C50 mmol L-1, respectively) [26]. Around 15% of
physically active participants in the present study had low
HDL-C. Physical inactivity is regarded as a cause of low
HDL-C levels [1] and exercise training tends to increase
HDL-C [3]; however, those with low HDL-C or ‘isolated
low HDL-C’ may be resistant to the HDL-raising effect of
exercise (isolated low HDL-C refers to low HDL-C in the
absence of other lipid abnormalities) [9–12]. The fibrate
class of drugs was tentatively recommended in those with
low HDL-C or high triglycerides/low HDL-C [2]. While
fibrate class can be effective in the secondary prevention of
non-fatal stroke, non-fatal myocardial infarction, and vas-
cular death, the beneficial effect relies on the inclusion of
clofibrate data [8]. Clofibrate was discontinued in 2002
because of unacceptably large adverse effects. The present
study suggests that physical activity could be recom-
mended in those with low HDL-C because it is associated
with reduced risk of mortality. The present study also
suggests that the relationships between physical activity,
low HDL-C and mortality are similar whether low HDL-C
is defined using the single or sex-specific definitions of
ATP III [1]. Sex-specific definitions of low HDL-C are
recommended in ATP III [1]; however, the present study
and a meta-analysis of 23 studies [7] suggest that the use of
a single definition or sex-specific definitions has little
influence on the association with CVD (the individual
participant data meta-analysis included 191,452 Asians and
28,608 non-Asians from the Asia–Pacific region [7]).
The inverse associations between physical activity and
mortality we have observed in those with normal and low
HDL-C are biologically plausible. It is well documented in
the general population that exercise training increases
cardiorespiratory fitness, increases insulin sensitivity,
reduces markers of inflammation, reduces blood pressure,
improves vascular function, and improves lipids and
lipoproteins [27]. The evidence in those with low HDL-C is
limited, but it would seem that exercise training also
increases cardiorespiratory fitness [9–12], reduces triglyc-
eride concentration [10], and improves the chemical and
physical characteristics of low-density lipoprotein choles-
terol [9]. The effect of exercise training on cardiorespira-
tory fitness may be particularly important because fitness
Fig. 1 Relative risk of all-cause
mortality with contributions
from different exposure
categories. The relative excess
risk due to interaction and the
attributable proportion due to
interaction are equal to 0 and
the synergy index is equal to 1
when there is no biological
interaction [25]
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may be a stronger predictor of mortality than smoking,
high cholesterol, and a number of traditional risk factors
[28]. It has also been estimated that, if physical inactivity
were to decrease by 25%, some 9% of deaths could be
avoided (ranging from 4% in low-income countries to 11%
in high-income countries) [29]. The population
attributable risk was higher in the present study because we
estimated what would happen if everybody were to adhere
to physical activity guidelines. High-density lipoprotein
cholesterol efflux capacity is inversely associated with
cardiovascular events [30] and it is also plausible that
exercise improves HDL-C functionality without modifying
HDL-C concentration [31].
There are few head-to-head comparisons of the effects
of exercise and drug interventions on mortality [32]. Net-
work meta-analysis can be used to combine direct evidence
(from trials that include a head-to-head comparison) and
indirect evidence (from a network of trials that do not
include the comparison). Naci and Ioannidis [32] reviewed
the literature to May 2013 and found 34 exercise inter-
ventions (10,984 participants), 165 drug trials (161,787
participants), and no head-to-head comparisons in the
secondary prevention of coronary heart disease. Network
meta-analysis revealed no statistically detectable differ-
ences in mortality between the exercise interventions and
drug trials [32]. Naci and Ioannidis [32] suggested that
there was a preference for drug trials in medical research
and that this preference had influenced clinical practice
guidelines; for example, they said, statins were only rec-
ommended after lifestyle interventions had been exhausted
in earlier versions of the National Cholesterol Education
Program guidelines [33].
Our study has some limitations. Ninety per cent of
participants were white and the results may not be gener-
alizable to other groups. Diet was not assessed. Physical
activity and HDL-C were only assessed at baseline and we
cannot account for changes over time. Physical activity was
self-reported; however, questionnaires are still regarded as
the mainstay of established surveillance studies such as
HSE and SHS [34]. We were unable to distinguish between
low HDL-C and isolated low HDL-C because triglyceride
concentrations were not available; however, there is little
distinction between the causes and treatment of both con-
ditions [1, 2]. We cannot discount the possibility of reverse
causation; however, in keeping with previous analyses in
the same cohorts [35, 36], we excluded deaths in the first
24 months of follow-up and we adjusted for longstanding
illness. The number of CVD deaths was relatively low,
which resulted in low statistical power in some
comparisons.
In conclusion, the present study suggests that the risks of
all-cause and CVD mortality are similar in both those who
meet physical activity guidelines and whose HDL-C
concentration is normal and those who meet physical
activity guidelines and whose HDL-C concentration is low.
This novel finding supports the notion that leisure-time
physical activity be recommended in those with low HDL-
C concentration.
Acknowledgements Hamer and Stensel acknowledge support from
the National Institute for Health Research (NIHR) Leicester
Biomedical Research Centre, which is a partnership between
University Hospitals of Leicester NHS Trust, Loughborough
University and the University of Leicester. Stamatakis is funded by
the National Health and Medical Research Council (NHMRC)
through a Senior Research Fellowship. The views expressed are those
of the authors and not necessarily those of the NHS, the NIHR, the
Department of Health, or the NHMRC.
Compliance with ethical standards
Conflict of interest The authors have no conflicts of interest to
declare.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. National cholesterol education program. Third report of the
national cholesterol education program (NCEP) expert panel on
detection, evaluation, and treatment of high blood cholesterol in
adults (adult treatment panel III) final report. Circulation.
2002;106(25):3143–421.
2. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent
clinical trials for the national cholesterol education program adult
treatment panel III guidelines. Circulation. 2004;110(2):227–39.
3. Kodama S, Tanaka S, Saito K, et al. Effect of aerobic exercise
training on serum levels of high-density lipoprotein cholesterol: a
meta-analysis. Arch Intern Med. 2007;167(10):999–1008.
4. Arem H, Moore SC, Patel A, et al. Leisure time physical activity
and mortality: a detailed pooled analysis of the dose-response
relationship. JAMA Intern Med. 2015;175(6):959–67.
5. O’Donovan G, Lee IM, Hamer M, Stamatakis E. Association of
‘‘Weekend Warrior’’and other leisure time physical activity pat-
terns with risks for all-cause, cardiovascular disease, and cancer
mortality. JAMA Intern Med. 10.1001/jamainternmed.2016.8014.
6. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol
as a risk factor for coronary heart disease mortality. A 21-year
follow-up of 8000 men. Arterioscler Thromb Vasc Biol.
1997;17(1):107–13.
7. Huxley RR, Barzi F, Lam TH, et al. Isolated low levels of high-
density lipoprotein cholesterol are associated with an increased
risk of coronary heart disease: an individual participant data
meta-analysis of 23 studies in the Asia-Pacific region. Circula-
tion. 2011;124(19):2056–64.
8. Wang D, Liu B, Tao W, Hao Z, Liu M. Fibrates for secondary
prevention of cardiovascular disease and stroke. Cochrane
Database Syst Rev 2015;10:CD009580.
The association between leisure-time physical activity, low HDL-cholesterol and mortality in… 565
123
9. Houmard JA, Bruno NJ, Bruner RK, McCammon MR, Israel RG,
Barakat HA. Effects of exercise training on the chemical com-
position of plasma LDL. Arterioscler Thromb.
1994;14(3):325–30.
10. Nicklas BJ, Katzel LI, Busby-Whitehead J, Goldberg AP.
Increases in high-density lipoprotein cholesterol with endurance
exercise training are blunted in obese compared with lean men.
Metabolism. 1997;46(5):556–61.
11. Zmuda JM, Yurgalevitch SM, Flynn MM, et al. Exercise training
has little effect on HDL levels andmetabolism inmenwith initially
low HDL cholesterol. Atherosclerosis. 1998;137(1):215–21.
12. Couillard C, Despres JP, Lamarche B, et al. Effects of endurance
exercise training on plasma HDL cholesterol levels depend on
levels of triglycerides: evidence from men of the health, risk
factors, exercise training and genetics (HERITAGE) family
study. Arterioscler Thromb Vasc Biol. 2001;21(7):1226–32.
13. Craig R, Deverill C, Pickering K, Prescott A. methodology and
response. In: Bromley C, Sproston K, Shelton N, editors. The
scottish health survey 2003. volume 4: technical report. Edin-
burgh: Crown; 2005. p. 1–48.
14. Craig R, Mindell J, Hirani V, editors. Health survey for England
2008. Volume 2: methods and documentation. London: National
centre for social research; 2010.
15. Stamatakis E, Hillsdon M, Primatesta P. Domestic physical
activity in relationship to multiple CVD risk factors. Am J Prev
Med. 2007;32(4):320–7.
16. Scholes S, Coombs N, Pedisic Z, et al. Age- and sex-specific
criterion validity of the health survey for England physical
activity and sedentary behavior assessment questionnaire as
compared with accelerometry. Am J Epidemiol.
2014;179(12):1493–502.
17. Joint health surveys unit. Health survey for England physical
activity validation study: substantive report. Leeds: information
centre for health and social care. 2007.
18. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 com-
pendium of physical activities: a second update of codes and
MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.
19. World health organisation. Global recommendations on physical
activity for health. Secondary global recommendations on phys-
ical activity for health. 2010. http://www.who.int/dietphysica
lactivity/factsheet_recommendations/en/.
20. Sabia S, Dugravot A, Kivimaki M, Brunner E, Shipley MJ,
Singh-Manoux A. Effect of intensity and type of physical activity
on mortality: results from the Whitehall II cohort study. Am J
Public Health. 2012;102(4):698–704.
21. Stamatakis E, Hamer M, Lawlor DA. Physical activity, mortality,
and cardiovascular disease: is domestic physical activity benefi-
cial? The Scottish Health Survey–1995, 1998, and 2003. Am J
Epidemiol. 2009;169(10):1191–200.
22. Craig R, Deverill C, Pickering K. Quality control of blood, saliva
and urine analytes. In: Spronston K, Mindell J, editors.
Methodology and documentation, vol. 2. London: The Informa-
tion Centre; 2006. p. 34–41.
23. Collins GS, Mallett S, Omar O, Yu LM. Developing risk pre-
diction models for type 2 diabetes: a systematic review of
methodology and reporting. BMC Med. 2011;9:103.
24. Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute
cardiovascular events placing the risks into perspective: a sci-
entific statement from the American heart association council on
nutrition, physical activity, and metabolism and the council on
clinical cardiology. Circulation. 2007;115(17):2358–68.
25. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom
A. Calculating measures of biological interaction. Eur J Epi-
demiol. 2005;20(7):575–9.
26. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density
lipoprotein cholesterol and cardiovascular disease. Four
prospective American studies. Circulation. 1989;79(1):8–15.
27. Hamer M, O’Donovan G. Cardiorespiratory fitness and metabolic
risk factors in obesity. Curr Opin Lipidol. 2010;21(1):1–7.
28. Ross R, Blair SN, Arena R, et al. Importance of assessing car-
diorespiratory fitness in clinical practice: a case for fitness as a
clinical vital sign: a scientific statement from the American heart
association. Circulation. 2016;134(24):e653–99.
29. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk
PT. Effect of physical inactivity on major non-communicable
diseases worldwide: an analysis of burden of disease and life
expectancy. Lancet. 2012;380(9838):219–29.
30. Rohatgi A, Khera A, Berry JD, et al. HDL cholesterol efflux
capacity and incident cardiovascular events. N Engl J Med.
2014;371(25):2383–93.
31. Trejo-Gutierrez JF, Fletcher G. Impact of exercise on blood lipids
and lipoproteins. J Clin Lipidol. 2007;1(3):175–81.
32. Naci H, Ioannidis JP. Comparative effectiveness of exercise and
drug interventions on mortality outcomes: metaepidemiological
study. Br J Sports Med. 2015;49(21):1414–22.
33. Program National Cholesterol Education. Summary of the second
report of the national cholesterol education program (NCEP)
expert panel on detection, evaluation, and treatment of high blood
cholesterol in adults (adult treatment panel II). JAMA.
1993;269(23):3015–23.
34. Pedisic Z, Bauman A. Accelerometer-based measures in physical
activity surveillance: current practices and issues. Br J Sports
Med. 2015;49(4):219–23.
35. O’Donovan G, Lee IM, Hamer M, Stamatakis E. Association of
‘‘Weekend Warrior’’ and other leisure time physical activity
patterns with risks for all-cause, cardiovascular disease, and
cancer mortality. JAMA Internal Med. 2017;177(3):335–42.
36. Hamer M, O’Donovan G, Stensel D, Stamatakis E. Normal-
weight central obesity and risk for mortality. Ann Intern Med.
2017;166(12):917–918.
566 G. O’Donovan et al.
123
